
Magellan Health, Inc. MGLN
Country |
|
IPO year |
- |
Industry |
Health care |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
25.8 M |
Market Cap[1] |
$ 2.49 B |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Health care"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Centene Corporation
CNC
|
$ 69.75 | -5.95 % | $ 34.4 B | NYSE,SPB | ||
|
UnitedHealth Group Inc.
UNH
|
$ 393.59 | -0.48 % | $ 357 B | NYSE,SPB | ||
|
Cigna Corporation
CI
|
$ 294.58 | -2.33 % | $ 77.6 B | NYSE,SPB | ||
|
CVS Health Corporation
CVS
|
$ 83.71 | 2.93 % | $ 106 B | NYSE,SPB | ||
|
Humana
HUM
|
$ 433.05 | 5.23 % | $ 52.2 B | NYSE,SPB | ||
|
Triple-S Management Corporation
GTS
|
- | 0.28 % | $ 847 M | NYSE | ||
|
NovoCure Limited
NVCR
|
$ 13.22 | -2.44 % | $ 1.47 B | Nasdaq Global Select Market,SPB | ||
|
Molina Healthcare
MOH
|
$ 208.4 | -3.79 % | $ 11 B | NYSE,SPB | ||
|
Anthem
ANTM
|
- | -2.32 % | $ 107 B | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.